Author(s): Taylor CJ, Layani L
Abstract Share this page
Abstract BACKGROUND: Laparoscopic adjustable gastric banding (LAGB) is an effective treatment for morbid obesity in younger patients, leading to improvements in related co-morbidities and quality of life. Currently, little is known how these improvements apply to older patients. METHODS: A prospective review was conducted of patients > or =60 years old undergoing LAGB. Weight loss, complications, changes in Short Form-36 (SF-36) scores, and a comprehensive post-operative co-morbidity, medication and quality of life questionnaire were used to assess performance. RESULTS: 40 patients with mean age 65.8 years (range 60-72) and preoperative mean BMI of 42.2 kg/m(2) (range 33-54) underwent LAGB from February 2000 to September 2005. Mean excess weight lost at 2 years was 54\%. 3 complications (7.5\%) occurred (1 slippage and 2 access-port infections). There were no perforations, erosions or deaths. After a mean postoperative interval of 27 months, SF-36 scores improved significantly in 4 of 8 components and exceeded age-matched population controls in 3 components. Co-morbidity improvement was reported in 80\% of patients with diabetes, 79\% with dyslipidemia, 75\% with obstructive sleep apnea, 72\% with heartburn, 69\% with hypertension, 60\% with musculoskeletal pain, and 56\% with anxiety/depression. Medication requirements reduced or ceased in 66\% who required musculoskeletal analgesics, 43\% of diabetics, 33\% using bronchodilators, and 29\% with hypertension. Sleep improved in 48\%, self-esteem increased in 70\%, and 72\% had a better outlook on life. 82\% were happy that they had undergone LAGB, and 91\% would recommend LAGB to other older people. CONCLUSION: LAGB offers safe and effective weight loss, and improvement in co-morbidities and in quality of life in morbidly obese patients aged > or =60 years.
This article was published in Obes Surg
and referenced in Journal of Obesity & Weight Loss Therapy